RUSTIC LANE
Manchester Terriers
Health
The health of dogs is essential to their quality of life and their ability to thrive as show dogs and companions. A healthy dog is more energetic, emotionally balanced, and better able to engage with people and other animals. Proper nutrition, regular exercise, routine veterinary care, and preventive measures such as vaccinations and parasite control all play a critical role in supporting a dog’s physical well-being. When these needs are met, dogs are less likely to suffer from chronic illnesses, pain, or mobility issues, allowing them to live longer, more comfortable lives.
Equally important is a dog’s mental and emotional health. Dogs that receive consistent care, social interaction, training, and enrichment are less prone to anxiety, aggression, and destructive behaviors. Mental stimulation and a stable environment help build confidence and trust, strengthening the bond between dogs and their owners. Prioritizing a dog’s overall health not only benefits the animal itself but also enhances the human–animal relationship, leading to a more fulfilling and harmonious companionship for both.
Manchester Terriers
Manchester Terriers are generally a healthy and long-lived breed, but like all purebred dogs, they are predisposed to certain congenital, genetic, and structural conditions. Patellar luxation is one of the most common structural issues seen in the breed, where the kneecap slips out of place, potentially causing lameness or arthritis over time. Legg-Calvé-Perthes disease, a hereditary condition affecting the hip joint, can also occur, particularly in younger dogs, leading to pain and degeneration of the femoral head if not treated. These orthopedic issues are especially important to monitor given the breed’s small size and athletic build.
Manchester Terriers are also known to be affected by several inherited eye conditions, including primary lens luxation, in which the lens of the eye shifts from its normal position and can lead to glaucoma or vision loss. Progressive retinal atrophy (PRA), though less common, has been documented and results in gradual blindness. On the metabolic and systemic side, the breed has a recognized risk for von Willebrand disease, a genetic bleeding disorder that can complicate surgery or injury due to impaired blood clotting. Additionally, some Manchester Terriers may be prone to hypothyroidism, which can manifest as weight gain, lethargy, and skin or coat issues.
Because many of these conditions have a genetic component, responsible breeding practices—including health testing and genetic screening—are crucial for reducing their prevalence. For owners, regular veterinary checkups, early screening, and attention to subtle changes in gait, vision, or behavior play an important role in maintaining the long-term health and quality of life of Manchester Terriers.
Von Willebrand’s Disease (vWD) is an inherited bleeding disorder that affects the blood’s ability to clot properly. It is caused by a deficiency or dysfunction of von Willebrand factor, a protein that helps platelets stick together and adhere to blood vessel walls after an injury. Without sufficient functional von Willebrand factor, bleeding can last longer than normal, even from minor cuts or routine procedures. The condition exists in varying degrees of severity, depending on how much the protein is reduced or impaired.
In dogs, vWD often goes unnoticed until an event such as surgery, trauma, or injury reveals abnormal bleeding. Common signs include prolonged bleeding from wounds, nosebleeds, bleeding gums, blood in urine or stool, or excessive bleeding after procedures like spaying, neutering, or tooth extractions. Some dogs may show only mild symptoms, while others—particularly those with more severe forms—can experience significant and potentially dangerous blood loss.
vWD is a genetic condition, meaning it cannot be cured, but it can be effectively managed. Diagnosis typically involves specialized blood tests, and in some breeds, genetic screening is available to identify affected or carrier dogs. Management focuses on prevention and preparedness: avoiding unnecessary surgical procedures, informing veterinarians in advance, and using supportive treatments such as clotting agents or transfusions when needed. With proper awareness and care, most dogs with von Willebrand’s Disease can live normal, active lives.
In Manchester Terriers, the condition does not usually present as progressive enlargement and weakening of the heart chambers over time. Instead, it is characterized by microscopic myocardial lesions—areas of abnormal or damaged heart muscle—that interfere primarily with the heart’s electrical conduction system rather than its mechanical pumping ability. As a result, affected puppies may appear outwardly healthy, active, and well-grown right up until the moment of collapse.
These lesions predispose the heart to fatal arrhythmias, which is why the condition is often grouped with Sudden Cardiac Death in Young Dogs (SCDY). Puppies may die suddenly during sleep, mild exertion, or play, often between a few weeks and several months of age, with little or no warning signs beforehand. Because the structural changes can be subtle or localized, routine auscultation may be normal, and even echocardiography can fail to detect the problem unless advanced testing (such as ECG or postmortem histopathology) is performed. This makes JDCM in Manchester Terriers particularly devastating and difficult to diagnose antemortem.
The condition is believed to be genetic and inherited, and its presence in the breed has driven strong emphasis on responsible breeding practices. Pedigree analysis, avoidance of affected lines, and transparency among breeders are currently the most effective tools for reducing its incidence, as there is no definitive genetic test or curative treatment available at this time. Because the disease mechanism is electrical rather than classic pump failure, traditional DCM management strategies offer little protection. Awareness of this breed-specific presentation is critical, as it explains why JDCM in Manchester Terriers can be so sudden, silent, and tragic despite the dogs otherwise appearing healthy.
Legg-Calvé-Perthes disease is a developmental orthopedic condition that primarily affects small and toy dog breeds during puppyhood, most often between four and twelve months of age. The disorder occurs when the blood supply to the head of the femur (the “ball” of the hip joint) is disrupted, leading to degeneration and collapse of the bone. As the femoral head deteriorates, the hip joint becomes painful and unstable, resulting in progressive lameness. The condition is not caused by trauma and is widely considered to have a genetic basis, making it an important concern in breeding programs.
Affected dogs typically develop a gradual, worsening limp in one hind leg, although both hips can be involved in some cases. Pain may become evident when the hip is manipulated, and muscle wasting of the affected leg is common as the dog avoids bearing weight. Without treatment, the irregular shape of the femoral head leads to arthritis and chronic discomfort. Diagnosis is usually confirmed through physical examination and radiographs, which reveal characteristic changes to the femoral head and hip joint.
Treatment depends on the severity of the disease and the size and age of the dog. Mild cases may be managed conservatively with strict rest, pain control, and physical therapy, but most dogs benefit from surgical intervention. The most common procedure, femoral head and neck ostectomy (FHO), removes the damaged portion of the bone, allowing a pain-free “false joint” to form. With proper surgery and rehabilitation, the long-term prognosis is generally excellent, and most dogs regain good mobility and enjoy an active, comfortable life.
Patellar luxation is a common orthopedic condition in dogs in which the patella, or kneecap, slips out of its normal groove in the femur. This condition is most frequently seen in small and toy breeds, though it can occur in dogs of any size. Patellar luxation is usually congenital, resulting from structural abnormalities in the alignment of the hip, femur, tibia, or muscles of the hind limb. These abnormalities cause uneven forces on the kneecap, allowing it to move medially (toward the inside of the leg) or, less commonly, laterally (toward the outside).
Dogs with patellar luxation may show intermittent skipping or hopping on a hind leg, sudden lameness, or stiffness after exercise. In mild cases, the kneecap may slip out and return to place on its own, causing only occasional discomfort. More severe cases can lead to persistent pain, difficulty walking, and reduced mobility, as the repeated displacement damages cartilage and contributes to the development of arthritis over time. The condition is typically graded on a scale from I to IV, with higher grades indicating more frequent or permanent displacement of the patella.
Treatment depends on the severity of the luxation and the dog’s clinical signs. Mild cases may be managed with weight control, exercise modification, physical therapy, and pain management. Moderate to severe cases often require surgical correction to realign the structures of the knee and stabilize the patella. When properly treated, especially if addressed early, most dogs experience significant improvement in comfort and function, allowing them to maintain an active and good quality of life.
Canine Primary Lens Luxation (PLL) is an inherited eye disorder in which the lens of the eye becomes displaced from its normal position due to weakening or breakdown of the ligaments that hold it in place. This condition most often affects young to middle-aged dogs and is seen in several terrier and small-breed lines. When the lens shifts, it can move either forward into the front chamber of the eye or backward into the vitreous chamber, disrupting normal eye function and placing pressure on other structures within the eye.
Clinical signs of PLL often appear suddenly and may include eye redness, cloudiness, squinting, excessive tearing, visible lens displacement, or signs of pain such as pawing at the face. One of the most serious complications is secondary glaucoma, which occurs when the displaced lens blocks normal fluid drainage and causes a rapid increase in eye pressure. Glaucoma can lead to permanent vision loss in a short period of time, making PLL a true veterinary emergency that requires prompt diagnosis and treatment.
Although PLL cannot be cured, early detection and appropriate management can significantly improve outcomes. Treatment options may include medications to reduce eye pressure and inflammation, or surgical removal of the displaced lens, particularly when glaucoma is present or imminent. Because PLL has a strong genetic component, DNA testing and responsible breeding practices are critical in reducing its incidence. For affected dogs, regular ophthalmic examinations and rapid response to eye changes are essential to preserving comfort and vision.
Canine xanthinuria (Type 2a) is a rare inherited metabolic disorder that affects the body’s ability to properly break down purines, which are natural components of many foods and normal cell turnover. In healthy dogs, purines are metabolized into uric acid and then further converted into allantoin, which is easily excreted in urine. In dogs with Type 2a xanthinuria, a deficiency in key enzymes involved in this pathway causes xanthine to accumulate instead. Because xanthine is poorly soluble, it can crystallize and form stones within the urinary tract.
Clinical signs of xanthinuria often relate to urinary obstruction or irritation. Affected dogs may show frequent urination, straining to urinate, blood in the urine, urinary accidents, or recurrent urinary tract infections. In severe cases, xanthine stones can block the urethra, creating a life-threatening emergency, particularly in male dogs. Unlike some other urinary stone conditions, xanthine stones do not show up well on standard X-rays, which can make diagnosis more challenging. Definitive diagnosis often requires stone analysis, specialized imaging, or genetic testing.
Management of canine xanthinuria focuses on prevention rather than cure, as the underlying genetic defect cannot be corrected. Treatment typically involves a lifelong low-purine diet to reduce xanthine production, along with increased water intake to dilute the urine and decrease the risk of crystal formation. Certain medications commonly used for other urinary conditions, such as allopurinol, must be avoided unless carefully managed, as they can worsen xanthine accumulation. With diligent dietary control, monitoring, and veterinary care, many dogs with Type 2a xanthinuria can live comfortable and active lives while minimizing the risk of painful urinary complications.
What can I do?
Become familiar with your breeder and their program
Canine husbandry and careful pedigree review play a vital role in protecting the long-term health of Manchester Terriers, particularly because the breed is small, genetically concentrated, and known to carry several serious inherited conditions. Good husbandry goes far beyond basic care; it includes thoughtful breeding decisions, appropriate age and health screening, proper nutrition, controlled growth in puppies, and lifelong veterinary monitoring. Because disorders such as Juvenile Dilated Cardiomyopathy (JDCM), von Willebrand disease, Primary Lens Luxation, and Xanthinuria can be silent or late-appearing, proactive management and prevention are far more effective than treatment after clinical signs emerge.
Pedigree review is especially critical in Manchester Terriers because some of the most devastating conditions—most notably JDCM associated with sudden cardiac death—may not be apparent through routine exams or even advanced imaging. Studying extended pedigrees allows breeders to identify patterns of early deaths, affected siblings, or repeated losses in specific lines, which can indicate hidden genetic risk even when parents appear healthy. When pedigree analysis is combined with modern genetic testing, it enables informed mate selection that avoids doubling up on known risk genes while still preserving genetic diversity, a key concern in a numerically small breed.
Responsible husbandry and pedigree stewardship ultimately benefit not only individual dogs but the breed as a whole. Transparent sharing of health information, collaboration among breeders, and willingness to make conservative breeding choices help reduce the prevalence of inherited disease over generations. For Manchester Terriers, where a single poor breeding decision can have profound consequences, diligent husbandry and pedigree review are among the most powerful tools available to ensure healthier dogs, fewer tragic losses, and a sustainable future for the breed.
Ensure healthier Manchester Terriers with genetic insights from the University of Minnesota’s Canine Genetics Lab! The Manchester Terrier / English Toy Terrier Health Panel offers DNA testing for key inherited conditions—including the gene variant linked to Juvenile Dilated Cardiomyopathy (JDCM) that can cause sudden cardiac death in young dogs, von Willebrand Disease Type 1, and Xanthinuria Type 2a—helping owners and breeders identify at-risk and carrier dogs before problems arise. With results that inform medical management and responsible breeding decisions, this testing empowers you to protect the long-term health and vitality of your dogs while preserving genetic diversity in the breed.